Navigation Links
ResearchDx and CompanDX Announce Strategic Partnership
Date:6/17/2011

IRVINE, Calif., June 17, 2011 /PRNewswire/ -- ResearchDx, LLC of Irvine, California today announced a strategic partnership with CompanDX of Nottingham UK.  ResearchDx and CompanDX have forged a unique partnership to offer a full capability to discover and deliver novel molecular diagnostic tests for clients in the healthcare setting.  CompanDX uses its unique "Distiller" platform to deliver small composite biomarker signatures from complex data of high dimensionality, which are commonplace in clinical development of therapeutics.  ResearchDx draws on its broad capability to design, produce and validate tests ready for the market and represents a new breed of service provider, the first CDO to offer turnkey solutions for companion diagnostic delivery.

"Our partnership with CompanDX completes our service offerings," said Founders of ResearchDx, Dr. Philip Cotter and Dr Mathew Moore.  "CompanDX's unique capabilities allow us to fully integrate bioinformatics into development of a diagnostic product from early in the discovery process. Our customers can trust ResearchDx to meet scientific challenges with a focus on their business priorities."

The new partnership will allow clients to initiate the parallel development of companion diagnostic tests from the very earliest stages of drug development.  CompanDX has developed a set of industry-leading tools to deliver definitive understanding of mechanism of action and biomarkers that describe patient response.  Andy Sutton, CEO of CompanDX commented, "ResearchDx occupies a space in the development of companion diagnostics that is highly complementary with our discovery platform.  Both companies strive to provide innovative solutions, cutting-edge capabilities, and outcome focused delivery. We are thrilled to dovetail into ResearchDx's downstream delivery by providing the biomarkers tailored to client's drug candidates that will form the basis of validated tests for use in the clinic."

ResearchDx is a Contract Diagnostics Organization (CDO) for the biopharmaceutical and diagnostic industries. The company provides comprehensive, integrated, flexible services for the in vitro diagnostic development process. From initial assay conceptualization, discovery, optimization and validation in a CAP/CLIA laboratory environment, through a complete set of clinical research services and on to regulatory approval, ResearchDx offers the services and solutions to meet complex diagnostics development needs.   ResearchDx's primary service areas include assay research and development, clinical laboratory services, clinical research, diagnostic manufacturing, and consulting.  Additional information is available at www.researchdx.com.   ResearchDx will be exhibiting at DIA 2011 in Chicago, IL, June 19 – 22, booth #1238 and Chairing the session "Pharma-Diagnostics Relationship" at the Next Generation DX Summit in Washington D.C., August 23 – 25, 2011.

CompanDX is a molecular diagnostics company focused on biomarker discovery that uses its unique "Distiller" platform to derive small composite biomarker panels defining patient populations of significant unmet need.  Working with Pharma and biotech companies CompanDX offers the opportunity to deliver stratified clinical trials utilizing companion diagnostic tests based on biomarkers derived from the "Distiller" bioinformatics platform. Privately-held, CompanDX is based in Nottingham, UK. Investors in the company include Lachesis and Mobius Funds. Additional information is available at www.compandx.com

Media Contact:

Philip D. Cotter, PhD, FACMG, FFSc (RCPA)
ResearchDx
Suite 147, 13766 Alton Parkway
Irvine, CA 92618
info@researchdx.com
866-225-9195 / 510-332-0477


'/>"/>
SOURCE ResearchDx
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
2. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
3. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
4. Anesiva Announces Second Quarter 2008 Financial Results and Update
5. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
6. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
7. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
8. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. ThirdBiotech Announces Kemeta as Newest Sponsor
10. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
11. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle ... people with peritoneal or pleural mesothelioma. Their findings are the subject of a new ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... OTTAWA, ON (PRWEB) , ... June 23, 2016 , ... ... former DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA ... joining the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. ...
Breaking Biology Technology:
(Date:6/9/2016)... attendance control systems is proud to announce the introduction of fingerprint attendance control software, ... employees are actually signing in, and to even control the opening of doors. ... ... ... Photo - http://photos.prnewswire.com/prnh/20160609/377487 ...
(Date:6/2/2016)... , June 2, 2016 The Department ... has awarded the 44 million US Dollar project, for the ... Vehicle Plates including Personalization, Enrolment, and IT Infrastructure , ... in the production and implementation of Identity Management Solutions. Numerous ... however Decatur was selected for the ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
Breaking Biology News(10 mins):